Literature DB >> 14500313

A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.

P H Jongerius1, P van Tiel, J van Limbeek, F J M Gabreëls, J J Rotteveel.   

Abstract

Drooling frequently occurs in children with multiple handicaps; application of anticholinergic drugs is a potential strategy to treat drooling. A computer aided search of original studies concerning the treatment of drooling was carried out. The methodological and statistical integrity of the identified studies were assessed with previously defined criteria. The articles were weighed for their separate contribution to the evidence. The search resulted in 64 reports, of which seven studies passed the screening and were subjected to further assessment and discussion by three referees. Because of the small number of reports and the methodological restriction within the studies, no meta-analysis could be performed. No general conclusion could be made about the efficacy of anticholinergic drugs in treatment of drooling in children with multiple handicaps. There was some evidence that three anticholinergic drugs (benztropine, glycopyrrolate, and benzhexol hydrochloride) are effective in the treatment of drooling, but it could not be concluded that one drug is preferable.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500313      PMCID: PMC1719306          DOI: 10.1136/adc.88.10.911

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

Review 1.  Drooling: review of the literature and proposals for management.

Authors:  J H Nunn
Journal:  J Oral Rehabil       Date:  2000-09       Impact factor: 3.837

2.  Management of drooling in cerebral palsy: three single case studies.

Authors:  S E Owen; M L Stern
Journal:  Int J Rehabil Res       Date:  1992       Impact factor: 1.479

3.  Use of benzhexol hydrochloride to control drooling of children with cerebral palsy.

Authors:  D Reddihough; H Johnson; M Staples; I Hudson; H Exarchos
Journal:  Dev Med Child Neurol       Date:  1990-11       Impact factor: 5.449

4.  Efficacy of benztropine therapy for drooling.

Authors:  J A Camp-Bruno; B G Winsberg; A R Green-Parsons; J P Abrams
Journal:  Dev Med Child Neurol       Date:  1989-06       Impact factor: 5.449

5.  Quantitative measurement of drooling.

Authors:  C Ekedahl; O Hallén
Journal:  Acta Otolaryngol       Date:  1973-05       Impact factor: 1.494

Review 6.  Drooling and its management in cerebral palsy.

Authors:  S R Harris; A H Purdy
Journal:  Dev Med Child Neurol       Date:  1987-12       Impact factor: 5.449

7.  Preliminary study of glycopyrrolate in the management of drooling.

Authors:  L M Stern
Journal:  J Paediatr Child Health       Date:  1997-02       Impact factor: 1.954

8.  Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.

Authors:  R J Mier; S J Bachrach; R C Lakin; T Barker; J Childs; M Moran
Journal:  Arch Pediatr Adolesc Med       Date:  2000-12

9.  Transdermal scopolamine for reduction of drooling in developmentally delayed children.

Authors:  D W Lewis; C Fontana; L K Mehallick; Y Everett
Journal:  Dev Med Child Neurol       Date:  1994-06       Impact factor: 5.449

10.  Glycopyrrolate treatment of chronic drooling.

Authors:  P A Blasco; J C Stansbury
Journal:  Arch Pediatr Adolesc Med       Date:  1996-09
View more
  14 in total

1.  Effect of botulinum toxin type a on morphology of salivary glands in patients with cerebral palsy.

Authors:  Zee-Ihn Lee; Dong-Hyun Cho; Won-Duck Choi; Dong-Hwi Park; Seung-Deuk Byun
Journal:  Ann Rehabil Med       Date:  2011-10-31

2.  [Drooling following radiation. Botulinum toxin as a successful treatment modality].

Authors:  A Steffen; B Wollenberg; R Schönweiler; N Brüggemann; T Meyners
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

3.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

4.  [Amyotrophic lateral sclerosis: management of bulbar symptoms].

Authors:  P Kraft; M Beck; A Grimm; C Wessig; K Reiners; K V Toyka
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

5.  Bilateral submandibular duct relocation by high-frequency radiosurgery.

Authors:  Gábor Katona; Zsuzsa Csákányi; Anikó Lorincz; Imre Gerlinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-05       Impact factor: 2.503

Review 6.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.

Authors:  Robert S Zeller; Hak-Myung Lee; Paul F Cavanaugh; Jennifer Davidson
Journal:  Ther Clin Risk Manag       Date:  2012-01-25       Impact factor: 2.423

Review 8.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

Review 9.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

Review 10.  Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.

Authors:  Andrée-Anne Poirier; Benoit Aubé; Mélissa Côté; Nicolas Morin; Thérèse Di Paolo; Denis Soulet
Journal:  Parkinsons Dis       Date:  2016-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.